Chapter 4 - Cultural, Legal, and Ethical Considerations (Flashcards)

0.0(0)
studied byStudied by 0 people
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/65

flashcard set

Earn XP

Description and Tags

Vocabulary-style flashcards covering cultural, legal, and ethical considerations in pharmacology and nursing, based on the provided notes.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

66 Terms

1
New cards

Ethnopharmacology

The study of how cultural factors influence drug response.

2
New cards

Pharmacogenomics

The study of how genetic traits affect drug response.

3
New cards

Drug polymorphism

Variability in drug response due to age, gender, size, body composition, environment, culture, and genetics.

4
New cards

Adherence

The extent to which patients follow a prescribed regimen; varies by culture and may be influenced by beliefs, education, family, expectations, and finances.

5
New cards

Environmental factors

Diet, nutrition, poverty, and access to care that affect drug response and adherence.

6
New cards

Pharmacokinetics/dynamics

How the body processes a drug and how the drug affects the body; influenced by genetics such as CYP450 differences.

7
New cards

Cultural meaning of medications

In some cultures, medications may symbolize weakness or mistrust of healthcare.

8
New cards

Cultural assessment

Nursing assessment of cultural factors that must be completed before giving drugs, including language, Health beliefs and practices, remedies, prior use medications use of herbal/home remediesm folk medicine, and OTC drugs ususal response to illness and treatments family/community support roles, dietatry habits, and religious practices.

9
New cards

Languages and interpreter need

Languages spoken, read, understood, and the need for an interpreter.

10
New cards

Health beliefs and practices

Beliefs such as yin/yang or hot/cold and the use of folk remedies.

11
New cards

Past use of medications

Historical use of medications that may affect current drug response or adherence.

12
New cards

Herbal/home remedies

Use of herbal medicines, folk remedies, and OTC products.

13
New cards

Religious practices

Religious beliefs or practices that may lead to refusal or modification of medications.

14
New cards

Family/community support

Roles of family and community in health decisions and care.

15
New cards

Dietary habits

Regular dietary patterns that can interact with drug effects or adherence.

16
New cards

African American health beliefs

Folk medicine, extended family, women often key decision-makers, and certain predispositions (e.g., lactose intolerance).

17
New cards

Asian health beliefs

hot/cold balance, acupuncture, herbalists; avoid handshakes opposite sex; family > individual; thalassemia, drug interactions, lactose intolerance.

18
New cards

Hispanic health beliefs

bad deed or bad luck; curandero, spiritualists; avoid eye contact (respect); touching common; strong family role; lactose intolerance.

19
New cards

Native American health beliefs

harmony with nature; medicine man; low tone voice, light touch; extended family; lactose intolerance, cleft uvula

20
New cards

Slow acetylators

People (often of European/African descent) with slower drug metabolism leading to higher drug levels.

21
New cards

Rapid acetylators

People (often of Japanese descent) with faster metabolism leading to lower drug levels.

22
New cards

CYP450 variations

Genetic differences in CYP450 enzymes affecting metabolism and drug response.

23
New cards

Asians as poor metabolizers

A subgroup in which certain CYP450 enzymes metabolize drugs slowly, risking toxicity.

24
New cards

Whites as ultrarapid metabolizers

A group with very fast drug metabolism requiring higher doses for effect.

25
New cards

Drug response in African Americans

Better response to diuretics and calcium channel blockers; less response to some beta-blockers/ACE inhibitors.

26
New cards

Ethnicity and dosing (Asians/Hispanics)

Often effective with lower doses of antidepressants, antipsychotics, and antianxiety meds.

27
New cards

FDA

The U.S. Food and Drug Administration; regulates drug approval, safety, and efficacy.

28
New cards

DEA

The Drug Enforcement Administration; enforces controlled substance laws.

29
New cards

State laws

State-level regulations governing prescribing privileges and nurse practice.

30
New cards

1906 Pure Food and Drug Act (FFDA)

Act requiring labels to list dangerous or addicting substances.

31
New cards

Harrison Narcotic Act (1914)

Law regulating narcotics and their distribution.

32
New cards

FFDCA (1938)

Act requiring safety testing and the IND process for drugs.

33
New cards

Durham-Humphrey Amendment (1951)

Established prescription ('legend') drugs separate from OTC drugs.

34
New cards

Kefauver-Harris Amendment (1962)

Required proof of efficacy and safety for drugs (thalidomide tragedy context).

35
New cards

Controlled Substances Act (1970)

Created scheduling of drugs from C-I to C-V based on abuse potential.

36
New cards

Orphan Drug Act (1983)

Promoted development of drugs for rare diseases.

37
New cards

Accelerated Review (1991)

Fast-track approval for HIV/AIDS and other urgent indications.

38
New cards

HIPAA (1996)

Law protecting patient privacy and health information.

39
New cards

Medicare Part D (2003)

Program providing prescription drug coverage under Medicare.

40
New cards

C-I schedule

Drugs with no accepted medical use and high abuse potential (e.g., heroin, LSD).

41
New cards

C-II schedule

Drugs with accepted medical use but high abuse potential (e.g., morphine, oxycodone).

42
New cards

C-III schedule

Drugs with less abuse potential and accepted medical use (e.g., codeine combos).

43
New cards

C-IV schedule

Drugs with lower abuse potential (e.g., benzodiazepines, tramadol).

44
New cards

C-V schedule

Drugs with the lowest abuse potential (e.g., certain cough/diarrhea preparations with opioids).

45
New cards

FDA Preclinical

In vitro and animal studies conducted before human testing.

46
New cards

Phase I-III (clinical trials)

Phases evaluating safety, dosage, and efficacy in humans; large populations tested.

47
New cards

Phase IV

Postmarketing surveillance after a drug is approved.

48
New cards

Black box warnings

The strictest FDA warning for serious or life-threatening risks.

49
New cards

Recalls (Class I-III)

FDA recall classifications by severity of risk to health.

  • Class I = severe risk/death.

  • Class II = reversible effects.

  • Class III = minor issues.

50
New cards

Legal Considerations in nursing

Governed by state/federal law, nurse practice acts, institutional policy

51
New cards

Nurse Practice Acts

State or national laws defining nursing scope of nursing,expanded roles, educational requirements, standards of care, and safe practice limits.

52
New cards

Liability in nursing

Legal responsibility for actions such as failure to assess, safety breaches, or fraud.

53
New cards

Nurses as patient advocates

Nurses must clarify unclear orders and document accurately to protect patients.

54
New cards

Ethical Considerations

ANA Code of Ethics, ICN Code of Ethics = frameworks

55
New cards

Ethical principles in nursing

Autonomy, beneficence, nonmaleficence, justice, veracity, and confidentiality.

56
New cards

Autonomy

Patients right to decide

57
New cards

Beneficence

Do good

58
New cards

Nonmaleficence

do no harm

59
New cards

Justice

Fairness

60
New cards

Veracity

truth-telling

61
New cards

confidentiality

Protect information. HIPPA reinformces

62
New cards

Placebos in research vs care

Placebos acceptable in research with informed consent; generally unethical in routine clinical care.

63
New cards

Cultural competence in nursing process

Assessment, planning, implementation, and evaluation tailored to cultural beliefs and practices.

64
New cards

Leininger & Giger-Davidhizar models

Cultural frameworks used to assess and apply culturally appropriate care.

65
New cards

Human Need Statements

Nursing diagnoses like altered sleep, deficient knowledge, or altered safety due to drug responses.

66
New cards

Adherence barriers

Factors like poverty, beliefs, and language that hinder medication adherence.